Kolkata, New Delhi, INDIA. New York, USA.
Business To Business, New Delhi, 24th July, 2026: The Food Safety and Standards Authority of India (FSSAI) has suspended the manufacturing licence of Rehaan Healthcare after detecting serious violations of food safety regulations at the company's health supplements and nutraceuticals production facility.
The regulator has directed the company to immediately halt the manufacture of its products, including digestive syrups, multivitamin syrups and other syrup-based food products, until all identified deficiencies are rectified and verified by the competent authority.
According to the FSSAI, production can resume only after the company addresses the regulatory shortcomings and receives clearance following an official inspection.
The food safety regulator also warned that legal action would be initiated if Rehaan Healthcare violates the suspension order or continues manufacturing activities without complying with the prescribed requirements.